These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 37449183)

  • 1. Targeted poverty alleviation initiatives and corporate sustainable value creation: Determining the role of corporate internal governance control in China.
    Bin-Feng C; Zhe L; Mirza SS; Safdar R
    Heliyon; 2023 Jul; 9(7):e17686. PubMed ID: 37449183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding the dynamics of capital structure, corporate governance, and corporate social responsibility in high- and low-leveraged US and Chinese firms.
    Mahmood AN; Arslan HM; Younas ZI; Komal B; Ali K; Mubeen M
    Environ Sci Pollut Res Int; 2023 Apr; 30(16):46204-46221. PubMed ID: 36710308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How do industry and province attributes impact corporate contribution to poverty alleviation: A multilevel analysis.
    Chen S; Yang G
    PLoS One; 2023; 18(10):e0293505. PubMed ID: 37883369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does CSR affect the cost of equity capital: Empirical evidence from the targeted poverty alleviation of listed companies in China.
    Yi Y; Xie B; Zhou L; Wei Y
    PLoS One; 2020; 15(2):e0227952. PubMed ID: 32032381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The peer effects of corporate poverty alleviation behavior: Empirical evidence from China.
    Fang K; Zheng L; Zhai N
    PLoS One; 2024; 19(7):e0304252. PubMed ID: 39008455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Firms' COVID-19 Pandemic Exposure and Corporate Cash Policy: Evidence from China.
    He Z; Suardi S; Wang K; Zhao Y
    Econ Model; 2022 Nov; 116():105999. PubMed ID: 36032988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does the risk of major customer need to be balanced? The role of customer concentration in corporate governance.
    Gao D; Ma J; Wang Y
    PLoS One; 2021; 16(11):e0259689. PubMed ID: 34752496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An empirical investigation of firm performance through corporate governance and information technology investment with mediating role of corporate social responsibility: Evidence from Saudi Arabia telecommunication sector.
    Alfalah AA; Muneer S; Hussain M
    Front Psychol; 2022; 13():959406. PubMed ID: 35959028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Relationship Between CEO Duality and Business Firms' Performance: The Moderating Role of Firm Size and Corporate Social Responsibility.
    Mubeen R; Han D; Abbas J; Álvarez-Otero S; Sial MS
    Front Psychol; 2021; 12():669715. PubMed ID: 35035363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Moderating Role of Corporate Social Responsibility in the Association of Internal Corporate Governance and Profitability; Evidence from Pakistan.
    Lu J; Javeed SA; Latief R; Jiang T; Ong TS
    Int J Environ Res Public Health; 2021 May; 18(11):. PubMed ID: 34071620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corporate governance and reporting quality of accounts in China-listed firms. A moderating role of ownership pattern.
    Sun H
    PLoS One; 2023; 18(11):e0295253. PubMed ID: 38033159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Environmental, social, and governance (ESG) performance and financial outcomes: Analyzing the impact of ESG on financial performance.
    Chen S; Song Y; Gao P
    J Environ Manage; 2023 Nov; 345():118829. PubMed ID: 37688968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corporate Competing Culture and Environmental Investment.
    Tian J; Cao W; Cheng Q; Huang Y; Hu S
    Front Psychol; 2021; 12():774173. PubMed ID: 35126237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corporate going-concern report in early pandemic situation: Evidence from Indonesia.
    Fidiana F; Yani P; Suryaningrum DH
    Heliyon; 2023 Apr; 9(4):e15138. PubMed ID: 37089310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unveiling the Effectiveness of Agency Cost and Firms' Size as Moderators Between CSR Disclosure and Firms' Growth.
    Akram A; Tang Y; Tariq J
    Front Psychol; 2020; 11():1624. PubMed ID: 32903572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corporate social responsibility, internal control, and firm financial performance.
    Zhang L; Su W
    Front Psychol; 2022; 13():977996. PubMed ID: 36660285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New insights into corporate sustainability, environmental management and corporate financial performance in European Union: an application of VAR and Granger causality approach.
    Ivascu L; Domil A; Sarfraz M; Bogdan O; Burca V; Pavel C
    Environ Sci Pollut Res Int; 2022 Nov; 29(55):82827-82843. PubMed ID: 35754081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does CSR governance matters for corporate value creation: exploring the nexus between corporate sustainability governance and investment efficiency of acquirers in Pakistan.
    Rustam A; Chengxuan G
    Environ Sci Pollut Res Int; 2023 Mar; 30(11):31768-31790. PubMed ID: 36454521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does financial transparency substitute corporate governance to improve stock liquidity? Evidence from emerging market of Pakistan.
    Ali S; Zhongxin W; Ali Z; Usman M; Zhuoping Y
    Front Psychol; 2022; 13():1003081. PubMed ID: 36452385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Impact of Financial Redundancy on Corporate Social Responsibility Performance: Evidence From Chinese Listed Firms.
    He L; Gan S; Zhong T
    Front Psychol; 2022; 13():882731. PubMed ID: 35664182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.